In NSCLC samples with RET fusion, co-occurring alterations were found in KRAS, SETD2, PBRL4, EZH1, and RRAGC genes.16 In addition to NSCLC, RET fusions have also been implied as part of the molecular profile in various other tumor types.17 This evidence concerns the gene EZH1 and non-small cell lung carcinoma.